FEDR 100 mg (Inrebic 100 mg)
Generic Name: fedratinib
Pill with imprint FEDR 100 mg is Brown, Capsule-shape and has been identified as Inrebic 100 mg. It is supplied by Celgene Corporation.
Inrebic is used in the treatment of myelofibrosis and belongs to the drug class multikinase inhibitors. Inrebic 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for FEDR 100 mg
Inrebic
- Generic Name
- fedratinib
- Imprint
- FEDR 100 mg
- Strength
- 100 mg
- Color
- Brown
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Celgene Corporation
- National Drug Code (NDC)
- 59572-0720
More about Inrebic (fedratinib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Drug images
- Pricing & coupons
- En español
- Drug class: multikinase inhibitors
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.